After the UK approves the Pfizer vaccine, the US vaccine injection counts down
After the UK approves the Pfizer vaccine, the US vaccine injection counts down
翻译结果
The UK has approved the listing of Pfizer vaccines produced by American companies. But in the United States, officials are still evaluating the two vaccines produced by Moderna and Pfizer, and 330 million Americans do not know when they will be vaccinated. The U.S. Food and Drug Administration (FDA) plans to meet on December 10 to discuss the vaccine developed by Pfizer/bioNTech. It will then meet again on December 17 to discuss Moderna’s emergency vaccination application. Previously, the number of confirmed cases of new crowns in the United States continued to increase, with an average of more than 150,000 new cases reported every day. According to data from Johns Hopkins University, a total of 13.6 million confirmed cases of new crowns and approximately 270,000 deaths have been recorded in the United States. The new crown vaccination is coming soon, four questions you should know New crown epidemic: Pfizer version of the vaccine is in sight, six major questions have answers New crown vaccine: Oxford vaccine successfully developed, three vaccines have their own advantages The UK takes the lead in approving the large-scale use of Pfizer's new crown vaccine, and high-risk groups start vaccination within a few days On Wednesday (December 2), the UK became the first country in the world to approve the use of Pfizer vaccine, which means that the UK can start mass injections next week. The elderly and medical workers will be listed as the highest priority vaccination targets, followed by those with underlying diseases, and then the vaccination order according to age. The UK’s approval is expected to put additional pressure on US regulators to quickly approve the vaccine. The US regulator will evaluate the same data as the UK. US Secretary of Health and Human Services Alexander Azar (Alexander Azar) said on Wednesday (December 2) that the British authorization is good news for Americans. While the US Food and Drug Administration is evaluating it, another independent regulatory agency's approval should give Americans more confidence in the quality of this vaccine," he said. British distribution experience can also help guide American authorities in related work. This vaccine must be stored at a temperature of minus 70°C and will be transported in a special box. Each box can hold up to 5000 doses. The vaccine must be packaged in dry ice. It can be stored in the refrigerator for 5 days after delivery. Once taken out of the refrigerator, it should be used within 6 hours. Federal officials from the Centers for Disease Control and Prevention (CDC) agreed that 21 million health care workers and 3 million elderly people living in nursing homes across the country should receive the vaccine first. But there is not much agreement on how the states should be allocated to other groups. Approximately 87 million front-line workers in the United States are expected to be the next injection targets, but it is up to the states to decide which industries to give priority to. For example, will postal workers and meat processing factory workers be included? Moncef Slaoui, the head of Operation Warp Speed, the US federal government's vaccine distribution program, said that he does not "expect a unified decision from the states." "Some states may prefer to let long-term care facilities or older people get vaccinated first, while others may give priority to their health care workers. It is wrong to vaccinate 18-year-old children first. I hope no one does that." Officials said they expect to vaccinate groups that are not at high risk in the spring of 2021. The question of how many Americans are willing to be vaccinated has also been a concern. A recent Gallup poll found that 58% of Americans are willing to be vaccinated, up from the lowest 50% in September. Minorities in the United States are at higher risk of contracting the virus and dying from the virus. Whether they are listed as a priority group for vaccination remains to be seen. The governor of New York last month condemned the federal government’s immunization program as discriminatory. He said that in black and Latino communities, infrastructure resources such as pharmacies and hospitals are relatively small. None of the vaccines currently being evaluated have been tested on pregnant or breastfeeding women, which means that the US government is unlikely to recommend the
